Outcomes of Rituximab for EBV Viremia/Post-Transplant Lymphoproliferative Disease in CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplantation
Autor: | Poppiti, Kristen *, Lin, Andrew *, Adel, Nelly G. *, Hilden, Patrick *, Castro-Malaspina, Hugo |
---|---|
Zdroj: | In Blood 2 December 2016 128(22):4623-4623 |
Databáze: | ScienceDirect |
Externí odkaz: |